Survivin – biology and potential as a therapeutic target in oncology
Open Access
- 1 October 2013
- journal article
- review article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. 6, 1453-1462
Abstract
Survivin is a member of the inhibitor-of-apoptosis proteins (IAPs) family; its overexpression has been widely demonstrated to occur in various types of cancer. Overexpression of survivin also correlates with tumor progression and induces anticancer drug resistance. Interestingly, recent studies reveal that survivin exhibits multiple pro-mitotic and anti-apoptotic functions; the differential functions of survivin seem to be caused by differential subcellular localization, phosphorylation, and acetylation of this molecule. In this review, the complex expression regulations and post-translational modifications of survivin are discussed. This review also discusses how recent discoveries improve our understanding of survivin biology and also create opportunities for developing differential-functioned survivin-targeted therapy. Databases such as PubMed, Scopus® (Elsevier, New York, NY, USA), and SciFinder® (CAS, Columbus, OH, USA) were used to search for literature in the preparation of this review.Keywords
This publication has 71 references indexed in Scilit:
- Histone Deacetylase 6 (HDAC6) Deacetylates Survivin for Its Nuclear Export in Breast CancerJournal of Biological Chemistry, 2012
- Aurora B kinase activation requires survivin priming phosphorylation by PLK1Journal of Molecular Cell Biology, 2010
- Acetylation Directs Survivin Nuclear Localization to Repress STAT3 Oncogenic ActivityJournal of Biological Chemistry, 2010
- Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosisCell Death & Disease, 2010
- Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL‐induced apoptosisFEBS Letters, 2010
- Liaisons between Survivin and Plk1 during Cell Division and Cell DeathJournal of Biological Chemistry, 2010
- γ-Secretase Inhibitors Abrogate Oxaliplatin-Induced Activation of the Notch-1 Signaling Pathway in Colon Cancer Cells Resulting in Enhanced ChemosensitivityCancer Research, 2009
- CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulationJournal of Biological Chemistry, 2008
- Compartmentalized Phosphorylation of IAP by Protein Kinase A Regulates CytoprotectionMolecular Cell, 2007
- The Survivin–Crm1 interaction is essential for chromosomal passenger complex localization and functionEMBO Reports, 2006